跳至主要内容
临床试验/ISRCTN05842222
ISRCTN05842222已完成不适用

Phase II randomized trial comparing 5-fluorouracil in continuous infusion and cisplatin (FP) versus leucovorin, bolus 5-fluorouracil and cisplatin (FLP) in metastatic gastric, pancreatic and oesophageal cancer

French Federation of Digestive Cancers (Fédération Francophone de la Cancérologie Digestive [FFCD]) (France)0 个研究点目标入组 232 人开始时间: 2005年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
232

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Histologically proven carcinoma of the oesophagus, the stomach or the pancreas, with a measurable metastatic disease (=15 mm) and without indication of radiotherapy and/or surgery; no prior chemotherapy for metastatic disease and, in case of adjuvant chemotherapy, no regimen containing cisplatin; age =75 years and World Health Organization (WHO) performance status <2; adequate baseline organ function, defined as neutrophile count =1500/mm^3, platelet count =100,000/mm^3 and creatinine level <1.25 normal level; in case of patient older than 70 years and/or creatinine level between 1 and 1.25 normal limit, creatinine clearance had to be more than 60 ml/mm; and written informed consent approved by the local Ethical Committee was given by all the participants before they entered the study.

排除标准

  • Severe uncontrolled co-morbidities, brain metastases

研究者

发起方
French Federation of Digestive Cancers (Fédération Francophone de la Cancérologie Digestive [FFCD]) (France)

相似试验